22:16 EDT Cybin announces renewed at-the-market equity program for up to $35M
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on CYBN:
- Cybin prepares for GMP manufacturing of CYB003 capsules for Phase 3 trial
- Cybin: USPTO grants patent covering deuterated psilocybin in CYB003 program
- Cybin price target lowered to $5 from $6 at Canaccord
- Cybin announces public offering of units
- Cybin teams with research firm Worldwide Clinical Trials to develop CYB003